HSP60 expression during carcinogenesis: where is the pilot? by Cappello, F. & Zummo, G.
ARTICLE IN PRESS0344-0338/$ - se
doi:10.1016/j.prPathology – Research and Practice 202 (2006) 401–402
www.elsevier.de/prpLETTER TO THE EDITORHSP60 expression during carcinogenesis: Where is the
pilot?
Dear Editor,
I have read with much interest the article of Mori et
al. [9], who used cDNA microarray and immunohisto-
chemical techniques to investigate the expression of four
upregulated genes in colorectal cancers, with HSP60
among them. In particular, they showed that HSP60 is
overexpressed in the cytoplasm of neoplastic cells, that
its intensity is stronger in deep invasive area than in
superﬁcial ones, and that carcinomas show stronger
immunoreactivity than adenomas. They provided data
that are in agreement with our previous results [1]. More
recently, we also showed that the expression of HSP60
in primary tumor and lymph node metastasis is
correlated with tumor grade [3], conﬁrming indepen-
dently the results of Mori et al.
In the past, we reported an analogous HSP60 over-
expression also in exocervical and prostatic carcinomas
[2,5]. Nevertheless, other authors [8] demonstrated
that HSP60 could also be downregulated during
carcinogenesis, especially the vesical one. We conﬁrmed
these data in a large series of bladder transitional cell
carcinomas of different grade and stage (unpublished
data).
Moreover, we recently reported that HSP60 down-
regulation may be a novel biomarker during bronchial
carcinogenesis [4]. Indeed, we analyzed a series of lung
biopsies from smokers, and showed that normal and
hyperplastic mucosae displayed cytoplasmic HSP60
expression in most of the epithelial cells, while only
few epithelial elements of patients with squamous
metaplasia showed the presence of HSP60 in epithelial
cells, and its positivity completely disappeared in
dysplastic and tumor specimens.
In this letter, we would like to express our opinion:
Currently, it is unlikely to conﬁrm that HSP60 over-
expression is correlated with cancer development and
progression, because it seems to depend on the site of
origin of the neoplasm. We presume that the discre-
pancy of HSP60 expression during carcinogenesis may
be due to its pro- and anti-apoptotic roles in tumor cellse front matter r 2006 Elsevier GmbH. All rights reserved.
p.2006.02.002[6,7], and we hypothesize that its levels are dependent on
the expression of other proteins involved in the
activation of the apoptotic pathway.
In conclusion, a better knowledge of the molecular
pathways, including HSP60 expression during carcino-
genesis, will probably expand our prognostic tools and
therapeutic targets in the treatment of cancer.References
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